Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
High-Risk Neuroblastoma
.
Show all posts
Showing posts with label
High-Risk Neuroblastoma
.
Show all posts
Friday, July 19, 2024
FDA Approves Iwilfin (eflornithine) as Maintenance Therapy for High-Risk Neuroblastoma
›
USWM, LLC announced the U.S. Food and Drug Administration (FDA) approval of Iwilfin ™ (eflornithine) 192 mg tablets, a groundbreaking oral...
›
Home
View web version
